- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01547650
Evaluation of Plasma Volume Using Ultrasound in Disorders of Fluid With Sodium
Rossi NF & Schrier RW reported that for having differential diagnosis in hyponatremic state, it is important to have a grasp of extra cellular fluid (ECF) volume. However, recent works showed that it is not easy to estimate the ECF state using by physical findings and by usual laboratory methods.
Damaraju SC et al. first demonstrated that measuring central venous pressure (CVP) is significant to evaluate the ECF state in hyponatremic patients with intracranial diseases. Accordingly, it may be useful to measure the CVP in the hyponatremic patients. However, usually it is difficult to measure the CVP in all patients with hyponatremia because that the method is due to invasive procedure. With recently development, it is possible to estimate the CVP calculation using cardiac echogram without invasion. However, it is not clear that an evaluation by using such echogram estimates the state of ECF volume in hyponatremic patients.
Therefore, the investigators examine whether the CVP calculation by using cardiac echogram by Marcelino P et al. method without invasion is estimated such condition in hyponatremic patients before and after treatments.
As the primary endpoint, the VCI index values is investigated and compared with each group before and after correction of disorders of fluid with sodium. Furthermore, some variables including sodium, potassium, chloride, creatinine, BUN, uric acid, osmolality in blood and urine and plasma vasopressin are investigated and compared with each group before and after correction of disorders of fluid with sodium.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Calculated CVP value as VCI (vena cava inferior) index by Marcelino P et al. method-they reported that VCI index using several echocardiographic parameters measured. A transthoracic echocardiographic study was performed using an Aloka SSD 2200 echocardiograph fitted with 2.5MHz probe with continuous-wave,pulsed and color Doppler (Japan). Using pulsed Doppler,each parameter is measured as following; the deceleration rime of E wave of tricuspid inflow,the gradient between right ventricle (RV) and right atrium (RA) by continuous Doppler,the VCI variation from the corresponding maximum expiratory diameter (measured at 2 cm from the RA and in dorsal decubitus) to its diameter during inspiration. All measurements were taken at the end-expiration in order to standardize the samples. VCI index = [tricuspid E deceleration (ms)] x 0.11 + [RV/RA gradient (mmHg)] x 0.16 - [VCI variation (mm)] (VCI, vena cava inferior; tricuspid E, tricuspid E wave; RV, right ventricle, RA, right atrium).
Na, Cl, K, creatinine, BUN and uric acid in serum and urine were measured by the usual methods before and after the correction of plasma volume. Further, osmolality and vasopressin in plasma and osmolality in urine were also measured by the usual methods.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Niigata
-
Nagaoka, Niigata, Japan, 940-2085
- Nagaoka Red Cross Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients with disorders of fluid with sodium including cerebral salt wasting syndrome (CSWS), syndrome of inappropriate antidiuretic hormone secretion (SIADH), primary polydipsia (PP), central diabetes insipidus (CDI) and others
- Patients more than 18 years old (gender is disregarded)
- Healthy subjects more than 18 years old (gender is disregarded)
Description
Inclusion Criteria:
Patients with disorders of fluid with sodium including cerebral salt wasting syndrome (CSWS), syndrome of inappropriate antidiuretic hormone secretion (SIADH), primary polydipsia (PP), central diabetes insipidus (CDI) and others
- Patients more than 18 years old (gender is disregarded)
- Healthy subjects more than 18 years old (gender is disregarded)
Exclusion Criteria:
Patients with a serious complication in the heart, liver or kidney
- Pregnant or possibly pregnant patients, or lactating patients
- Patients complicated with a malignant tumor at present.
- Patients participating in other clinical study.
- Other than the above, patients judged inappropriate as the subjects of this study by the investigator
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
SIADH, CSWS, CDI, PP, DIH, HF
CSWS (cerebral salt wasting syndrome), SIADH (syndrome of inappropriate ADH) , CDI (central diabetes insipidus), PP (primary polydipsia), DIH (drug-induced hyponatremia), HF (heart failure with hyponatremia)
|
Before and after the correction of plasma volume
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Calculated CVP by using cardiac echogram
Time Frame: within the first 30 days (plus or minus 3 days) after correcting status of plasma volume
|
within the first 30 days (plus or minus 3 days) after correcting status of plasma volume
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kyuzi Kamoi, MD, Nagaoka Red Cross Hospital and University of Niigata Prefecture
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3-Kamoi
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Other Diagnoses and Conditions
-
Children's Hospital SrebrnjakGlaxoSmithKline; University Hospital Rijeka; Clinical Hospital Center, Split; General... and other collaboratorsCompletedSmoking | COPD | Other Diagnoses, Comorbidities, and ComplicationsCroatia
-
Instituto Aragones de Ciencias de la SaludAndaluz Health Service; Instituto de Salud Carlos III; Red de Investigación en... and other collaboratorsCompletedMultimorbidity | Polypharmacy | Other Diagnoses, Comorbidities, and ComplicationsSpain
-
The University of Hong KongQueen Mary Hospital, Hong KongUnknownOther Diagnoses and ConditionsChina
-
Ward of the 21st CenturyCanadian Institutes of Health Research (CIHR); Alberta Health services; University...CompletedOther Diagnoses, Comorbidities, and ComplicationsCanada
-
University Hospital, AkershusTerminatedBipolar Disorder | Psychosis | Other Diagnoses and ConditionsNorway
-
University of Texas Southwestern Medical CenterCompletedDepression | Other Diagnoses, Comorbidities, and ComplicationsUnited States
-
Yale UniversityPatient-Centered Outcomes Research InstituteCompletedMental Health Wellness 1 | Mental Illnesses | Other Diagnoses, Comorbidities, and Complications | PatientUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedStudy Focusing on Integrated Versus Non-integrated Psychiatric Care in | Opioid-dependent and Methadone Treated Patients With Other Psychiatric | DiagnosesUnited States
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI)CompletedAssociations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of LifeHematologic Malignancies | Other Diagnoses, Comorbidities, and ComplicationsUnited States
-
Oslo University HospitalNorwegian Centre for Mental Disorders Research (NORMENT)CompletedSchizophrenia | Bipolar Disorder | Cardiovascular Risk Factor | Inpatient Facility DiagnosesNorway
Clinical Trials on Calculated CVP by using cardiac echogram
-
University of AlbertaCompletedMyocardial Injury | Death, Cardiac | Myocardial Infarction PostoperativeCanada
-
University of Texas Southwestern Medical CenterForest LaboratoriesCompletedHypertensionUnited States